Statistical optimization of compression coated ketoprofen tablet using amylose/ethyl cellulose mixture for colonic delivery by Devi, Nirmala & Sharma, Manju
Journal of Applied Pharmaceutical Research ISSN No. 2348 – 0335 www.japtronline.com 
 
 
January – March 2015 Volume 3                                       Issue 1  10 
 
For Correspondence 
nirmalapharma21@gmail.com 
STATISTICAL OPTIMIZATION OF COMPRESSION COATED KETOPROFEN TABLET USING 
AMYLOSE/ETHYL CELLULOSE MIXTURE FOR COLONIC DELIVERY 
Nirmala Devi1*, Manju Sharma2 
1. Shridhar University Pilani-Chirawa Road, Pilani-333 031 (Rajasthan) 
2. Faculty of Pharmacy, Hamdard University,New Delhi 
 
In the present study the effect of two independent factors (amount of ethyl cellulose in coating layer and coating level) on ketoprofen 
release from compression coated tablet in order to optimize coated tablet for colonic delivery. 3 2 factorial design was used for 
designing coated formulation. Amount of ethyl cellulose (X1) and coating level (X2) were selected as independent variables. The 
studied responses were drug release at 5 hr (Y1) and drug release at 10 hr (Y2). The core tablets were compression coated with 
different ratio of amylose and ethylcellulose. In vitro drug release study was carried out in pH1.2 for 2 hr, pH 7.4 for 3 hr and goat 
caecal medium for 5 hr. Drug release revealed that amount of ethyl cellulose and coating level have antagonistic effect on drug 
release. Multiple regression analysis was used for generation of polynomial equation and optimization of formulation. The optimized 
formulation consisted of ethyl cellulose (14.33 %) and coating level (318 mg) provided a release profile that is closed to estimated 
values. The model is found to be accurate and robust for optimization of compression-coated tablet for colonic delivery of 
ketoprofen. 
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INTRODUCTION 
Colon targeted drug delivery provides better options in the 
treatment of many diseases of colon such as colon cancer, 
ulcerative colitis, chron’s disease etc. Colon targeted drug 
delivery system also has improvised systemic absorption of 
polypeptides and many other drugs susceptible to enzymatic 
digestion in the upper gastrointestinal tract (1-4).  
There are various approaches used for colon targeted drug 
delivery including time dependent, pH dependent, GI pressure 
dependent and colonic microflora enzyme activated systems. 
Time dependent approach is a less reliable option due to high 
inter-subject variability in gastric emptying time. The pH 
dependent approach has also poor colon specificity due to less 
difference in pH between small intestine and colon. Specific 
enzyme secretions by colonic microflora makes enzyme 
activated systems as the most reliable approach (5-7). In this 
orbit, most suitable carrier for colon targeted drug delivery is 
polysaccharides (8-12). Among these carriers, amylose is a 
viable one which is an unbranched linear polymer of 
glycopyranose units (α-1,4-D glucose) linked through α-D (1-
4) linkage. It is resistant to pancreatic amylase but it degraded 
by the colonic bacterial enzyme (13). Amylose has been used 
as matrix and coating material for oral delayed released 
formulations intended for colon targeting (14-17). However, 
pure amylose takes up considerable amounts of water upon 
contact with aqueous body fluids. Due to the very permeable 
nature of the amylose, the drug has been released before the 
colon is reached. To overcome this drawback, water insoluble 
polymers are used with amylose for colon targeted drug 
delivery (18).  
Pharmaceutical industry mostly used solvent coating 
techniques. But these techniques have several drawbacks such 
as time consuming nature; drug stability for heat labile and 
hydrolysis; costly and environment pollution. To overcome 
these, non solvent coating techniques were gained interest in 
recent years. Among non solvent techniques compression 
coating is the simple and cost effective. Now a day 
compression coating is often used for hydroscopic and heat 
sensitive drugs; to separate incompatible drugs in fixed dose 
combination and to modify drug release pattern.  
Ketoprofen has been used as a model drug in the present study, 
which is a propionic acid class non-steroidal anti-inflammatory 
drugs (NSAIDs). NSAIDs are widely utilized in the treatment 
of chronic inflammatory bowel disease. Moreover, they 
showed an effective role in prevention and treatment of colitis 
and colon cancers (19-22). However, once they are 
administered orally, a large amount of the drug is absorbed 
from the upper GIT, and causes systemic side effects. 
Therefore, it is preferred to deliver the drug targeted to the 
colon. 
 
Experimental design is an effective statistical tool to study 
simultaneously the effect independent formulation variables at 
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different levels on various responses. A growing body of 
published literatures indicated the application of factorial 
design approach for colon-targeted formulations by many 
researchers (7, 23, 24).   
The present study aims at the preparation of an optimized 
compression coated tablet formulation and evaluation of the 
same for better colonic drug delivery. The study also deals with 
the effect of two variables on the release profile of ketoprofen 
by utilizing a factorial design approach to get an optimized 
formulation where the two variables mentioned, includes the 
amount of ethyl cellulose and the coating level. 
 
MATERIALS AND METHOD 
Ketoprofen was received as a gift sample from Alembic 
Pharmaceuticals; India. Glassy amporphus amylose was 
obtained from Shekharr Starch Pvt. Ltd.; Mumbai, India. All 
other materials such as microcrystalline cellulose, cross linked 
polyvinyl pyrrolidone, corn starch, magnesium stearate and 
ethyl cellulose were obtained from SD Fine Chemicals Ltd.; 
Mumbai, India. 
 
Experimental Design 
In this study, a 32 factorial design was used for optimisation of 
the formulation. The independent variables were percentage of 
ethyl cellulose (X1) and coating level (X 2). The dependent 
variables were percentage of drug release in 5 hr (Y1) and 
percentage of drug release in 10 hr (Y2). The formulation 
design along with values for variables is presented in the table 
1 & 2.  
Table 1: Factor and responses for experimental design 
Independent variables 
(Factor) 
Dependent variables 
(Response) 
Level X1 X 2 Y1 =Percentage Drug 
release at 5 hr (Q 5) -1 0 300 
0 20 400 Y 2= Percentage Drug 
release at 10 hr (Q 10) +1 40 500 
X1 – Ethyl cellulose content (%);  X 2 – Coating level 
 
The science behind the selection of the above dependent 
variables is supported by the fact that colon targeted delivery 
becomes successful when the release rate obeys a slow or nil 
profile in the upper GIT and a subsequent optimum release rate 
profile in the colonic environment. For a successful colonic 
drug delivery system, it is essential to release the drug in the 
colonic environment without any release in the upper GIT. A 
slow release in the upper GIT can also be acceptable to a 
considerable extent. Therefore, the dependent variables i.e. the 
time points (5 hr& 10 hr) are very much significant for the 
study design. 
 
Table 2: Experimental Design lay out and observed Results 
Std 
order 
Formulation 
Independent 
variables 
(Factor) 
Dependent 
variables 
(Response) 
X1 X 2 Y1 Y2 
1 F 1 -1 -1 28.35 98.65 
2 F 2 0 -1 16.32 70.39 
3 F 3 1 -1 10.66 56.72 
4 F 4 -1 0 26.61 94.08 
5 F 5 0 0 15.89 62.98 
6 F 6 1 0 8.83 48.02 
7 F 7 -1 1 25.1 93.2 
8 F 8 0 1 13.82 56.73 
9 F 9 1 1 6.98 40.72 
X1 indicates ethyl cellulose content (%); X2 indicates coating 
level (mg); Y1 indicates Percentage Drug release at 5 hr (Q 5); 
Y2 indicates Percentage Drug release at 10 hr (Q 10) 
 
Preparation of ketoprofen containing core tablet 
Ketoprofen core tablet was prepared by direct compression 
method. Each core tablet contained ketoprofen (50 mg), 
microcrystalline cellulose (60 mg) and sodium starch glycolate 
(5mg). Mixture of stearate (1 %) and talc (2 %) was added as 
lubricant. Core tablets (diameter 6 mm, average tablet weight 
120 mg) were compressed within 6 mm of punches on cadmach 
16 station compression machine under a common compression 
force of 3-4 kg/cm2.The core tablets were evaluated for 
hardness, content uniformity, thickness, friability and 
dissolution performed in different dissolution medium (pH 1.2, 
6.8, 7.4) . 
 
Coating of core tablets 
The core tablets were compression coated with different ratio 
of amylose and ethyl cellulose. Half amount of polymer blend 
placed in the die cavity; the core tablet positioned centrally in 
the die cavity. Die cavity was filled with remaining half 
amount of polymer blend. The coating material compressed 
around the core tablet within 12 mm of punches on cadmach 
16-station compression machine under common compression 
force of 5-6 kg/cm2. 
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In vitro drug release study 
The integrity of compression-coated tablets of ketoprofen in 
physiological environment of upper gastrointestinal tract was 
evaluated by performing dissolution study under condition 
mimicking mouth to colon transit environment. The dissolution 
test was carried out using the USP XXXIII type II apparatus 
(paddle apparatus TDL 08 L; Electrolab India Pvt Ltd, 
Mumbai, India) with a rotation speed of 100 RPM in 0.1 N HCl 
(900 ml) for 2 hr. Then the dissolution medium was replaced 
with pH 7.4 Sorensen’s phosphate buffer (900 ml) and further 
studied for the next 3 hrs. At specified time points, 5 ml sample 
was taken, suitably diluted and analyzed for ketoprofen content 
using HPLC method (25). To study enzymatic action of colonic 
bacteria on amylose, the dissolution study was continued in 900 
ml of pH 6.8 phosphate buffer saline using goat caecal content 
up to 10 hr (26). 
 
RESULT AND DISCUSSION 
The ketoprofen core tablet was prepared by direct compression 
method. The average  weight of core tablet was found to be 
120±1.3 mg. The hardness was found to be in the range of 3-4 
kg/cm2. Weight loss in friability test was found to be less than 
0.5 %, indicating compliance with acceptance limit. The mean 
drug content of core tablet was found to be 98.23±1.39 %.The 
core tablets were also found to comply with the disintegration 
test as the core tablet disintegrate within 15 minute.  
 
The thickness of core tablet was found to be 1.64± 0,04 mm. 
The drug release profile (Fig 1) of core tablet in various 
medium (pH 1.2, 6.8, 7.4) shows no lag time. More than 75 % 
of the drug was found to be released within the initial 30 
minutes. 
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Figure 1. In vitro drug release profile of core tablet at pH 1.2, 
pH 6.8 & pH 7.4 
Nine compression-coated formulations were suggested by 32 
factorial designs for two dependent variables i.e., amount of 
ethyl cellulose (X1) and coating level (X2). The post 
compression parameters of compression coated tablets were 
presented in table 3.  
 
The dissolution studies of coated tablets were carried out at pH 
1.2 for 2 hr, pH 7.4 for 3 hr and pH 6.8 (goat cecal content) till 
10 hr. The drug release profiles of coated tablets are shown in 
figure 2. At pH 1.2, coated formulations demonstrated very less 
drug release (below 6.5%). At pH 7.4 (simulated intestinal 
fluid), coated tablets demonstrated drug release not more than 
20 %.The result showed a minimal drug release in 
physiological environment of stomach and small intestine. It is 
anticipated that presence of hydrophobic polymer (ethyl 
cellulose) in coating layer, prevents leaching of drug in to 
upper GIT medium. 
 
The drug release of compression coated tablets in pH 7.4 for 3 
hr (simulated intestinal fluid) revealed that formulations (F1, F 
3, F7) containing only amylase shows drug release 28.35  %, 
26.6 % and 25.1 % for F1, F 3 and F7 respectively. This 
indicated that single coating of amylose was not suitable to 
prevent drug release in small intestine. As the hydrophobic 
content (ethyl cellulose) added up to 20 % in coating layer (F 2, 
F 5, F 7) drug release at 5 hr was found to be decreased. 
Formulation F4, F 5 and F 8 released 16.32 %, 15.89 % and 
13.83 % of drug at 5 hr respectively. On further increase in 
ethyl cellulose content from 20 % to 40 % in formulations (F3, 
F6, F9), drug release at 5 hr was found to be diminished to 
10.66 %, 8.83 % and 6.93 % for F3, F6 and F9 respectively. 
This demonstrated that increase in hydrophobic content (ethyl 
cellulose) in coating layer, minimized drug release in small 
intestine.  
 
Amylose swelled in presence of the medium, which leads to a 
disruption in the structure of coating layer and formulation of 
aqueous filled pores through which drug release can occur. 
Ethyl cellulose is insoluble in nature and poorly swellable in 
aqueous medium. Ethyl cellulose prevent water uptake and 
drug release in upper GIT. As coating level was increased, drug 
release in pH 7.4 was found to be diminished. This might be 
due to increase in diffusion path length. 
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Table 3: Post compression characteristics of various formulation (F 1-F 10) 
Formu- 
lation 
code 
Parameter 
Thickness  
(mm)  
Weight  
(mg)  
Hardness 
(Kg/cm
2
)  
Friability  
(%)  
Assay 
(%) 
F 1 2.51±0.12 421.34±2.31 5.4±0.13 0.62±0.08 100.65±2.32  
F 2 2.54±0.21 419.64±2.49 5.6±0.18 0.53±0.03 100.45 ± 2.93 
F 3 2.58±0.11 420.72± 2.21 5.7±0.19 0.62±0.04 103.11±1.93 
F 4 3.42±0.19 520.18± 3.42 5.9±0.21 0.64±0.08 101.33 ± 1.43 
F 5 3.46±0.21 521.89±2.86 5.8±0.14 0.73±0.05 103.12±2.92 
F 6 3.44±0.12 522.34±3.43 5.3±0.24 0.78±0.06 100.71 ±2.74 
F 7 4.42±0.15 621.32±2.23 6.1±0.14 0.58±0.03 102.49 ± 1.84 
F 8 4.39± 0.17 619.31±1.98 5.9± 0.12 0.73±0.02 100.21 ± 2.21 
F 9 4.37±0.19 622.32±2.94 6.2 ± 0.15 0.81±0.06 100.68 ± 1.94 
F 10 4.19±0.21 500.23±2.80 5.4±0.14 0.57±0.04 100.38 ± 2.12 
 
Table 4: Coefficient and p-value of each factor, for response Y1 and Y2 
Factor Y1 Y2 
Coefficient p-value Coefficient p-value 
X1 -8.93 <0.0001 - 23.41 <0.0001 
X2 -1.57 0.0037 - 5.85 0.0009 
X12 -0.11 0.6765 - 2.64 0.0166 
X1
2 2.41 0.0053 8.53 0.0016 
X2
2 -0.24 0.5225 1.04 0.2671 
 
Table 5: Result of Analysis of variance (ANOVA) 
Source of Variation Df SS MS F R
2
 p-value 
ResponseY1,  Drug release at 5 hr (%) 
Model 3 505.10 168.37 1034.47 0.9984 < 0.0001 
Residual 5 0.81 0.16    
Total 8 505.91     
ResponseY2,  Drug release at 10 hr (%) 
Model 4 3667.49 916.87 644.36 0.9985 < 0.0001 
Residual 4 5.69 1.42    
Total 8 3673.18     
DF indicates: degrees of freedom; SS, sum of squares; MS, mean of squares; F, fischer's ratio; R2 , regression coefficient.. 
 
To determine the effect of colonic enzymes on ketoprofen 
release, dissolution studies were further carried out in pH 6.8 
containing goat caecal content for next 5 hr. All the 
formulations demonstrated a rapid drug release in the initial 
hour. This could be due to degradation of amylose in the coat 
by bacterial amylase normally found in colon. The tablets only 
coated with amylose (F 1, F 4, F 7) showed rapid drug release 
in goat cecal medium and drug release was found to be 98.65 
%, 94.02 % and 93.20 % at 10 hr respectively. Amylose was 
rapidly fermentable in the colon and ethyl cellulose is non 
fermentable in the colon. Therefore amylose and ethyl cellulose 
are unsatisfactory as sole coating agent and it is necessary to 
blend both in order to improve the mechanical properties of 
coat for successful colon targeted drug delivery(17). Drug 
release of tablets containing 20 % ethyl cellulose was found to 
be 70.39 %, 62.98 % and 56.73 % at 10 hr for F 2, F 5 & F 8 
Figure 2 In vitro drug release profile of compression coated 
formulations in pH 1.2(2 hr), pH 7.4 (3 hr) and pH 6.8 
containing goat caecal (5 hr) 
Significant factor (p < 0.05).All bold values have p- value > 
0.05, hence considered insignificant.   
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respectively. On further increasing ethyl cellulose content from 
20 % to 40 %, the drug release was found to be decreased to 
56.72 %, 48.02 % and 40.72 % at 10 hr for F 3, F 6 and F 9 
respectively. It is suggested that ethylcellulose had prevented 
the disruption of coat thereby retarding the drug release.When 
the coat thickness increased, drug release in caecal content 
medium was found to be slower. A multivariate optimization 
was carried out in order to find optimum ethyl cellulose content 
and coating level to achieve a optimum colon targeted drug 
delivery from a compression coated tablets. The statistical 
analysis of the response was performed by one-way ANOVA 
using Design Expert software version 7.0.0. F test was used to 
evaluate individual response. To establish a relationship 
between independent and dependent variables, polynomial 
equation was generated using multiple linear regression 
analysis. The polynomial equation generated that fitted to data 
was as follow: 
Yi=b0+b1X1+b2X2+b12X1X2+b11X1
2+b22X2
2        ……. (Eq.1)  
 
Where Y is the response (dependent variable), b0 is the 
arithmetic mean of all the outcomes of 9 runs ; b1, b2, b12, b11, 
b12 are the coefficient computed from the observed 
experimental value; and X1, X2 stands for average result of 
changing one factor at a time  from its low value to high value. 
The X1& X2 interaction term shows the response when two 
response simultaneously changed. The quadratic term (X1
2 & 
X2
2) were used to imitate non linearity of design space.The 
mathematical equations of responses are as follow: 
𝑌1 = +15.50 − 8.93𝑋1 − 1.57𝑋2 − 0.11𝑋1𝑋2 + 2.41𝑋1
2 −
0.24𝑋2
2                                                              …….… (Eq. 2)  
Y2=+62.67 − 23.91X1—5.85X2 − 2.64X1X2 + 8.53X1
2
− 1.04X2
2                                                                 …….… (Eq. 3) 
 
Table 4 shows the factor effect of model and respective P 
values for responses Y1 and Y2. A factor significantly affects 
the response, if p value is less than 0.05. X1X2 and X2
2were 
found to be non-significant for response Y1. For response Y2, 
X2
2was found to be insignificant. A backward elimination 
procedure by eliminating non significant term (p > 0.05) was 
adopted to fit the data in to different predictor equations.  
 
The final equation of the responses is given below: 
Y1=+15.50 − 8.93X1 − 1.57X2 + 2.41X1
2   ….… (Eq. 4) 
Y2=+63.37 − 23.41X1—5.85X2 − 2.64X1X2 + 8.53X1
2 
…(Eq. 5)  
Table 5 shows result of analysis of variance (ANOVA). Larger 
F value and high R square value indicated that models were 
significant and valid. 
To validate the polynomial mathematical model, dissolution of 
four random formulations covering the entire range of 
independent variables were performed. For each of these 
formulations, value of X1 and X2 were substituted to estimate 
response Y1 and Y2. Table 6 shows the experimental condition 
of random formulations, predication and observed value of 
responses along with percentage prediction error. Linear 
correlation curve (Fig.3) between observed and predicated 
responses, establish a close agreement (r2> 0.98). Robustness 
of mathematical model is demonstrated by significant value of 
r2 and lower value of percentage predication error (-2.80- 3.61 
for response Y1 & -2.46- 2.61 for response Y2.  
 
Figure 3. Linear correlation curve (A & B) between observed 
and predicated value for response Y1 (drug release at 5 hr) and 
Y2 (drug release at 10 hr) 
The three dimensional response surface graphs were 
constructed by using quardratic model for graphical 
representation of effect of factors on each response. Figure 4 
depicts the effect of two dependent variables on drug release at 
5 hr (Q5).  
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Table 6: Comparison between observed and predicated value 
for response Y1 (Percentage Drug release at 5 hr) and Y 2 
(Percentage Drug release at 5 hr) for different check points 
Factors 
(Coaded) 
Response Observed 
value 
Predicated 
value 
Percent 
predication 
error X1 X2 
0.30 -
0.50 
Y 1 14.13 13.62 3.61 
Y 2 58.21 59.64 -2.46 
-0.50 0.8 Y 1 18.63 19.15 -2.80 
Y 2 75.34 73.58 + 2.33 
0.8 0.4 Y 1 9.46 9.11 3.70 
Y 2 48.09 46.92 2.34 
0.5 -0.8 Y 1 12.26 12.73 - 3.83 
Y 2 61.13 59.53 2.61 
 Percent predication error was calculated by using formula 
 𝑜𝑏𝑠𝑒𝑟𝑣𝑒𝑑  𝑣𝑎𝑙𝑢𝑒 −𝑝𝑟𝑒𝑑𝑖𝑐𝑎𝑡𝑒𝑑  𝑣𝑎𝑙𝑢𝑒  
𝑂𝑏𝑠𝑒𝑟𝑣𝑒𝑑  𝑣𝑎𝑙𝑢𝑒
𝑥 100 
 
Figure 4. Response surface plot showing the influence of ethyl 
cellulose content (X1) and coating level (X2) on response 
Y1(drug release at 5 hr)  
The figure shows that both factors have a negative effect on 
response Y1 (Q5). This might be due to decrease permeability 
of coating layer as ethyl cellulose content increases. Diffusion 
path length also gets increased by increasing coating level. 
However, the effect of ethyl cellulose content is little more 
significant than coating level. This is also supported by 
polynomial equation for response Y1 and table 4. Figure 5 
shows a curvilinear relationship of response Y2 with both the 
factors. This can be due to interaction between two variables, 
interpreting that each factor is inclining to change the effect of 
another factor towards the drug release in caecal content 
medium. Q 10 is decreased on increasing either of the factors. 
This may be due to decreased permeability and more torus path 
length because of the water insolubility of ethyl cellulose along 
with increase in coating thickness. The effect of ethyl cellulose 
content on Q 10 seems to be more than coating thickness. This 
is also supported by the polynomial equation for response Y2 
(Q10). This is in agreement with the fact that when coating 
material is soluble in dissolution medium, the coating level is 
not an effective factor for sustaining the drug release (27). 
 
Figure 5: Response surface plot showing the influence of ethyl 
cellulose content (X1) and coating level (X2) on response 
Y2(drug release at 10 hr) 
A numerical optimization technique was used to develop an 
optimized formulation. Constraints for responses are shown in 
table 7. The optimal values of factors were: ethyl cellulose 
content, 14.22 % and coating level 318.38 mg. 
 
Table 7: Optimization of compression coated tablet 
Constraints 
Name Goal Lower limit Upper Limit 
Amount of 
ethyl cellulose 
(%) 
In range 0 40 
Coating Level In range 300 500 
Cumulative 
drug release at 
5 hr (%) 
In range 6.98 20 
Cumulative 
drug release at 
10 hr (%) 
Target ≥ 75 40.72 98.65 
SOLUTION (F 10) 
Amount of 
ethyl 
cellulose 
(%) 
Coating 
Level 
Cumulative 
drug 
release at 
5hr (%) 
Cumulative 
drug 
release at 
10 hr (%) 
Desirability 
14.22 318.38 19.4091 75 1.00 
Design-Expert® Software
Q 5
28.35
6.98
X1 = A: amount of EC
X2 = B: coting level
  0.00
  10.00
  20.00
  30.00
  40.00
300.00  
350.00  
400.00  
450.00  
500.00  
6  
11.75  
17.5  
23.25  
29  
  
Q
 5
  
  A: amount of EC    B: coting level  
Design-Expert® Software
Q 10
98.65
40.72
X1 = A: amount of EC
X2 = B: coting level
  0.00
  10.00
  20.00
  30.00
  40.00
300.00  
350.00  
400.00  
450.00  
500.00  
39  
54  
69  
84  
99  
  
Q
 1
0
  
  A: amount of EC    B: coting level  
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In vitro dissolution study of optimum formulation was 
performed. Figure 6 shows drug release pattern of optimum 
formulation.  
 
Figure 6 In vitro drug release profile of optimum formulation 
(F 10) 
 
Table 8 shows a close agreement between predicated and 
experimental value.  
Table 8: Predicated and observed responses of optimum 
formulation (F 10) 
Response Observed 
value 
Predicated 
value 
Percent 
predication 
error 
Y 1 18.56 19.40 - 4.52 
Y 2 76.31 75 1.71 
Y1 indicates Percentage Drug release at 5 hr (Q 5); Y2 
indicates Percentage Drug release at 10 hr (Q 10). 
 
Percent predication error was calculated by using formula 
 𝑜𝑏𝑠𝑒𝑟𝑣𝑒𝑑  𝑣𝑎𝑙𝑢𝑒 −𝑝𝑟𝑒𝑑𝑖𝑐𝑎𝑡𝑒𝑑  𝑣𝑎𝑙𝑢𝑒  
𝑂𝑏𝑠𝑒𝑟𝑣𝑒𝑑  𝑣𝑎𝑙𝑢𝑒
𝑥 100 
 
CONCLUSION 
It was concluded that factorial design was a successful tool for 
optimization of compression coated tablet based on amylose 
and ethyl cellulose in order to achieve colonic delivery. The 
optimized formulation containing ethyl cellulose (14.22 %) and 
coating level (318 mg) showed Q5 (18.56 %) and Q10 (76.31 
%) , which were found to be  close to the predicated values. 
Thus the developed coated tablet can be a reliable approach for 
colonic drug delivery. 
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